These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18755577)

  • 41. The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.
    Rodvelt KR; Oelrichs CE; Blount LR; Fan KH; Lever SZ; Lever JR; Miller DK
    Drug Alcohol Depend; 2011 Jul; 116(1-3):203-10. PubMed ID: 21277708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice.
    Wang J; Mack AL; Coop A; Matsumoto RR
    Eur Neuropsychopharmacol; 2007 Nov; 17(11):708-16. PubMed ID: 17376658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of methamphetamine's locomotor stimulation and self-administration by JHW 007, an atypical dopamine reuptake blocker.
    Ferragud A; Velázquez-Sánchez C; Canales JJ
    Eur J Pharmacol; 2014 May; 731():73-9. PubMed ID: 24675149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methamphetamine-induced spectrin proteolysis in the rat striatum.
    Staszewski RD; Yamamoto BK
    J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y; Martin JL; Ali SF
    Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
    Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH
    J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.
    Seminerio MJ; Robson MJ; Abdelazeem AH; Mesangeau C; Jamalapuram S; Avery BA; McCurdy CR; Matsumoto RR
    AAPS J; 2012 Mar; 14(1):43-51. PubMed ID: 22183188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.
    Xie T; Tong L; Barrett T; Yuan J; Hatzidimitriou G; McCann UD; Becker KG; Donovan DM; Ricaurte GA
    J Neurosci; 2002 Jan; 22(1):274-83. PubMed ID: 11756511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions.
    Xu L; Chen LY
    Chem Biol Drug Des; 2021 Jun; 97(6):1194-1209. PubMed ID: 33754484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic methamphetamine administration causes differential regulation of transcription factors in the rat midbrain.
    Krasnova IN; Ladenheim B; Hodges AB; Volkow ND; Cadet JL
    PLoS One; 2011 Apr; 6(4):e19179. PubMed ID: 21547080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.
    Kuczenski R; Segal DS; Melega WP; Lacan G; McCunney SJ
    Neuropsychopharmacology; 2009 Oct; 34(11):2430-41. PubMed ID: 19571794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.
    Lever JR; Fergason-Cantrell EA; Watkinson LD; Carmack TL; Lord SA; Xu R; Miller DK; Lever SZ
    Synapse; 2016 Mar; 70(3):98-111. PubMed ID: 26618331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization.
    Cen X; Nitta A; Ibi D; Zhao Y; Niwa M; Taguchi K; Hamada M; Ito Y; Ito Y; Wang L; Nabeshima T
    Mol Psychiatry; 2008 Apr; 13(4):349, 451-63. PubMed ID: 18195717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
    Gou H; Wen D; Ma C; Li M; Li Y; Zhang W; Liu L; Cong B
    Behav Brain Res; 2015 Apr; 283():87-96. PubMed ID: 25629941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.
    Vieira-Brock PL; McFadden LM; Nielsen SM; Ellis JD; Walters ET; Stout KA; McIntosh JM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2015 Dec; 355(3):463-72. PubMed ID: 26391161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
    Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
    Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
    Melega WP; Jorgensen MJ; Laćan G; Way BM; Pham J; Morton G; Cho AK; Fairbanks LA
    Neuropsychopharmacology; 2008 May; 33(6):1441-52. PubMed ID: 17625500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.